Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Wednesday, May 22, 2024 | Back issues
Courthouse News Service Courthouse News Service

Pharmaceuticals

SAN FRANCISCO — A federal court in California granted partial summary judgment to McKesson in a class action accusing the pharmaceutical distributor of misleading investors by failing to disclose that a generic drug price-fixing scheme was boosting its profits. The class is amended to include those who acquired the company’s stock from Oct. 24, 2013, through Jan. 11, 2016.

Read the order here.

Categories / Briefs, Business, Health, Law

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...